Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug;475(2):191-199.
doi: 10.1007/s00428-019-02595-9. Epub 2019 Jul 1.

Impact of delayed and prolonged fixation on the evaluation of immunohistochemical staining on lung carcinoma resection specimen

Affiliations

Impact of delayed and prolonged fixation on the evaluation of immunohistochemical staining on lung carcinoma resection specimen

Maartje van Seijen et al. Virchows Arch. 2019 Aug.

Abstract

Pre-analytical factors, such as fixation time, influence morphology of diagnostic and predictive immunohistochemical staining, which are increasingly used in the evaluation of lung cancer. Our aim was to investigate if variations in fixation time influence the outcome of immunohistochemical staining in lung cancer. From lung resections, specimen with tumor size bigger than 4 cm, 10 samples were obtained: 2 were put through the standard fixation protocol, 5 through the delayed, and 3 through the prolonged fixation protocol. After paraffin embedding, tissue microarrays (TMAs) were made. They were stained with 20 antibodies and scored for quality and intensity of staining. Samples with delay in fixation showed loss of TMA cores on glass slides and deterioration of tissue quality leading to reduction in the expression of CK 7, Keratin MNF116, CAM 5.2, CK 5/6, TTF-1, C-MET, Napsin A, D2-40, and PD-L1. Prolonged fixation had no influence on the performance of immunohistochemical stains. Delay of fixation negatively affects the expression of different immunohistochemical markers, influencing diagnostic (cytokeratins) and predictive (PD-L1) testing. These results emphasize the need for adequate fixation of resection specimen.

Keywords: Fixation; Immunohistochemistry; Lung adenocarcinoma; Pre-analytical.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Example of a CK 7 (Monosan) staining after normal fixation (a) and after 96 h delay in fixation (b). A is scored as sufficient and B as insufficient quality, due to prominent non-specific (background) staining (for both objective × 15)
Fig. 2
Fig. 2
The distribution of PD-L1 (E1L3N (XP)) staining divided in 4 categories is shown for samples with delay in fixation. Of note, the number of cases with positive PD-L1 staining (1–49% and ≥ 50%) is lower after delay in fixation
Fig. 3
Fig. 3
Presentation of PD-L1 staining in a tumor sample after normal fixation (a), after 6 h (b), 48 h (c), and 96 h (d) of delay in fixation (for all objective × 20). Note: deterioration of membrane staining in 48+ h delayed fixation and increase of non-specific staining

References

    1. Bass BP, Engel KB, Greytak SR, Moore HM. A review of preanalytical factors affecting molecular, protein, and morphological analysis of formalin-fixed, paraffin-embedded (FFPE) tissue: how well do you know your FFPE specimen? Arch Pathol Lab Med. 2014;138:1520–1530. doi: 10.5858/arpa.2013-0691-RA. - DOI - PubMed
    1. Neumeister VM. Tools to assess tissue quality. Clin Biochem. 2014;47:280–287. doi: 10.1016/j.clinbiochem.2014.02.016. - DOI - PubMed
    1. Prinsen CFM, Klaassen CHW, Thunnissen FBJM. Microarray as a model for quantitative visualization chemistry. Appl Immunohistochem Mol Morphol. 2003;11:168–173. doi: 10.1097/00129039-200306000-00014. - DOI - PubMed
    1. Thunnissen E, Allen TC, Adam J, Aisner DL, Beasley MB, Borczuk AC, Cagle PT, Capelozzi VL, Cooper W, Hariri LP, Kern I, Lantuejoul S, Miller R, Mino-Kenudson M, Radonic T, Raparia K, Rekhtman N, Roy-Chowdhuri S, Russell P, Schneider F, Sholl LM, Tsao MS, Vivero M, Yatabe Y (2017) Immunohistochemistry of pulmonary biomarkers: a perspective from members of the pulmonary pathology society. Arch Pathol Lab Med arpa.2017-0138-SA. 10.5858/arpa.2017-0106-SA - PubMed
    1. Torlakovic EE, Cheung CC, D’Arrigo C, Dietel M, Francis GD, Gilks CB, Hall JA, Hornick JL, Ibrahim M, Marchetti A, Miller K, van Krieken JH, Nielsen S, Swanson PE, Vyberg M, Zhou X, Taylor CR, From the International Society for Immunohistochemistry and Molecular Morphology (ISIMM) and International Quality Network for Pathology (IQN Path) Evolution of quality assurance for clinical immunohistochemistry in the era of precision medicine. Part 3: technical validation of immunohistochemistry (IHC) assays in clinical IHC laboratories. Appl Immunohistochem Mol Morphol AIMM. 2017;25:151–159. doi: 10.1097/PAI.0000000000000470. - DOI - PubMed

MeSH terms

Substances